___

• [1] Breast cancer facts & figures 2019-2020. Atlanta: American Cancer Society, Inc 2019.2019 Available online from: https://www.cancer.org/research/cancer-facts-statistics/breast-cancer-facts-figures.html
• [2] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer Journal for Clinicians 2018,68:394-424.
• [3] Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK: Various types and management of breast cancer: An overview. Journal of Advanced Pharmaceutical Technology and Research 2010,1 (2):109-26.
• [4] Breast Cancer: Stages. Breast Cancer Guide.2020 Available online from: https://www.cancer.net/cancer-types/breast-cancer/stages
• [5] Mathur P, Sathishkumar K, Chaturvedi M, Das P, Kondalli LS, Santhappan S, et al.: Cancer statistics, 2020: Report from national cancer registry programme, India. JCO Global Oncology 2020(6):1063-75.
• [6] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al.: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer Journal for Clinicians 2021,0:1-41.
• [7] Breast Cancer Guide. Breast Cancer: Types of Treatment.2020 Available online from: https://www.cancer.net/cancer-types/breast-cancer/types-treatment
• [8] Park K: Nanotechnology: What it can do for drug delivery. Journal of Controlled Release 2007,120 (1-2):1-3.
• [9] Jagdale SC, Shah TP, Kuchekar BS, Chabukswar AR, Baviskar DT: Cancer Nanotechnology. Asian Journal of Pharmaceutics 2009:1-7.
• [10] Jain RK, Stylianopoulos T: Delivering nanomedicine to solid tumors. Nature Reviews Clinical Oncology 2010,7 (11):653-64.
• [11] Sapra P, Tyagi P, Allen TM: Ligand-targeted liposomes for cancer treatment. Current Drug Delivery 2005,2 (4):369-81.
• [12] Srinivasa GS, Yarema KJ: Dendrimers in Cancer Treatment and Diagnosis. In: Kumar CSSR, editor. Nanotechnologies for the Life Sciences, WILEY-VCH Verlag GmbH & Co. ; Weinheim: 2007. pp. 1-43.
• [13] Kandekar UY, Chaudhari PD, Tambe VS, Vichare VS, Dhole SN: Dendrimers: novel drug nanocarriers. International Journal of Pharmaceutical Sciences and Research 2011,2 (5):1086.
• [14] Marcinkowska M, Stanczyk M, Janaszewska A, Sobierajska E, Chworos A, Klajnert-Maculewicz B: Multicomponent conjugates of anticancer drugs and monoclonal antibody with PAMAM dendrimers to increase efficacy of HER-2 positive breast cancer therapy. Pharmaceutical Research 2019,36 (11):1-17.
• [15] Kulhari H, Pooja D, Shrivastava S, Kuncha M, Naidu VGM, Bansal V, et al.: Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer. Scientific Reports 2016,6 (1):23179.
• [16] Salimi M, Sarkar S, Hashemi M, Saber R: Treatment of breast cancer-bearing balb/c mice with magnetic hyperthermia using dendrimer functionalized iron-oxide nanoparticles. Nanomaterials 2020,10 (11):2310.
• [17] Chittasupho C, Anuchapreeda S, Sarisuta N: CXCR4 targeted dendrimer for anti-cancer drug delivery and breast cancer cell migration inhibition. European Journal of Pharmaceutics and Biopharmaceutics 2017,119:310-21.
• [18] Jaiswal M, Dudhe R, Sharma PK: Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech 2015,5:123-7.
• [19] Mendes Miranda SE, Alcântara Lemos Jd, Fernandes RS, Silva JdO, Ottoni FM, Townsend DM, et al.: Enhanced antitumor efficacy of lapachol-loaded nanoemulsion in breast cancer tumor model. Biomedicine & Pharmacotherapy 2021,133:110936.
• [20] Salehi F, Behboudi H, Kavoosi G, Ardestani SK: Incorporation of Zataria multiflora essential oil into chitosan biopolymer nanoparticles: A nanoemulsion based delivery system to improve the in-vitro efficacy, stability and anticancer activity of ZEO against breast cancer cells. International journal of biological macromolecules 2020,143:382-92.
• [21] Periasamy VS, Athinarayanan J, Alshatwi AA: Anticancer Activity of an Ultrasonic Nanoemulsion Formulation of Nigella sativa L. Essential Oil on Human Breast Cancer Cells. Ultrason Sonochem 2016,31:449-55.
• [22] Migotto A, Carvalho VFM, Salata GC, da Silva FWM, Yan CYI, Ishida K, et al.: Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer. Drug Delivery 2018,25 (1):654-67.
• [23] Saifuddin, Raziah NAZ, Junizah AR: Carbonnanotubes: A review on structure and their interaction with proteins. Journal of Chemistry 2013:1-18.
• [24] De Volder MFL, Tawfick SH, Baughman RH, Hart AJ: Carbon nanotubes: present and future commercial applications. Science 2013,339:535-9.
• [25] Tajabadi M: Application of carbon nanotubes in breast cancer therapy. Drug Research 2019:1-5.
• [26] Edgar Pérez-Herrero, Alberto Fernández-Medarde: Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. European Journal of Pharmaceutics and Biopharmaceutics 2015,93:52-79.
• [27] Dizaji BF, Farboudi A, Rahbar A, Azarbaijan MH, Asgary MR: The role of single- and multi-walled carbon nanotube in breast cancer treatment. Therapeutic Delivery 2020,11 (10).
• [28] Ozgen PSO, Atasoy S, Kurt BZ, Durmus Z, Yigit G, Dag A: Glycopolymer decorated multiwalled carbon nanotubes for dual targeted breast cancer therapy. Journal of Materials Chemistry B 2020,8 (15):3123-37.
• [29] Badea MA, Prodana M, Dinischiotu A, Crihana C, Ionita D, Balas M: Cisplatin loaded multiwalled carbon nanotubes induce resistance in triple negative breast cancer cells. Pharmaceutics 2018,10 (4):228.
• [30] Zhang H, Ji Y, Chen Q, Jiao X, Hou L, Zhu X, et al.: Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles. Journal of Drug Targeting 2015,23 (6):552-67
• [31] Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M: Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005,21 (23):10644-54.
• [32] Luna-Gutiérrez M, Ferro-Flores G, Ocampo-García BE, Santos-Cuevas CL, Jiménez-Mancilla N, León-Rodríguez D, et al.: A therapeutic system of 177Lu-labeled gold nanoparticles-RGD internalized in breast cancer cells. Journal of the Mexican Chemical Society 2013,57 (3):212-9.
• [33] Kapara A, Brunton V, Graham D, Faulds K: Investigation of cellular uptake mechanism of functionalised gold nanoparticles into breast cancer using SERS. Chemical Science 2020,11 (22):5819-29.
• [34] Abdolahinia ED, Nadri S, Rahbarghazi R, Barar J, Aghanejad A, Omidi Y: Enhanced penetration and cytotoxicity of metformin and collagenase conjugated gold nanoparticles in breast cancer spheroids. Life sciences 2019,231:116545.
• [35] Vemuri SK, Rajkiran RB, Mukherjee S, Uppula P, Gpv S, Reddy GAV, et al.: Novel biosynthesized gold nanoparticles as anti-cancer agents against breast cancer: Synthesis, biological evaluation, molecular modelling studies. Materials Science and Engineering: C 2019,99:417-29.
• [36] Rokade SS, Joshi KA, Mahajan K, Patil S, Tomar G, Dubal DS, et al.: Gloriosa superba mediated synthesis of platinum and palladium nanoparticles for induction of apoptosis in breast cancer. Bioinorganic Chemistry and Applications 2018,2018.
• [37] Suganya UKS, Govindaraju K, Prabhu D, Arulvasu C, Karthick V, Changmai N: Anti-proliferative effect of biogenic gold nanoparticles against breast cancer cell lines (MDA-MB-231 & MCF-7). Applied Surface Science 2016,371:415-24.
• [38] Khan SA, Kanwal S, Rizwan K, Shahid S: Enhanced antimicrobial, antioxidant, in vivo antitumor and in vitro anticancer effects against breast caner cell line by green synthesized un-doped SnO2 and Co-doped SnO2 nanoparticles from Clerodendrum inerme. Microbial Pathogenesis 2018,125:366-84.
• [39] Nayak D, MinzAliva Prity , Ashe S, Rauta PR, Kumari M, chopra P, et al.: Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines. Journal of Colloid and Interface Science 2016,15 (470):142-52.
• [40] Chang Y, Jiang J, Chen W, Yang W, Chen L: Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer. Applied Materials Today 2020,18:100492.
• [41] Kumari A, Yadav SK, Yadav SC: Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and surfaces B: biointerfaces 2010,75 (1):1-18.
• [42] Du M, Ouyang Y, Meng F, Ma Q, Liu H, Zhuang Y, et al.: Nanotargeted agents: an emerging therapeutic strategy for breast cancer. Nanomedicine 2019,14 (13):1771-86.
• [43] Chen S-H, Liu T-I, Chuang C-L, Chen H-H, Chiang W-H, Chiu H-C: Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer. Journal of Materials Chemistry B 2020,8 (17):3789-800.
• [44] Hu C, Fan F, Qin Y, Huang C, Zhang Z, Guo Q, et al.: Redox-sensitive folate-conjugated polymeric nanoparticles for combined chemotherapy and photothermal therapy against breast cancer. Journal of Biomedical Nanotechnology 2018,14 (12):2018-30.
• [45] Cho H-J, Yoon I-S, Yoon HY, Koo H, Jin Y-J, Ko S-H, et al.: Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Biomaterials 2012,33 (4):1190-200.
• [46] Potineni A, Lynnb DM, Langerb R, Amiji MM: Poly(ethylene oxide)-modified poly(b-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery. Journal of Controlled Release 2003,86:223-34.
• [47] Khanna C, Rosenberg M, Vail DM: A review of paclitaxel and novel formulations including those suitable for use in dogs. Journal of Veterinary Internal Medicine 2015,29 (4):1006-12.
• [48] Miele E, Spinelli GP, Miele E, Tomao F, Tomao S: Albumin-bound formulation of paclitaxel (Abraxane®ABI-007) in the treatment of breast cancer. International Journal of Nanomedicine 2009,4:99-105.
• [49] Chen S-H, Liu T-I, Chuang C-L, Chen H-H, Chiang W-H, Chiu H-C: Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer. Journal of Material Chemisry B 2020,8 (17):3789-800.
• [50] Zhou Y, Chen D, Xue G, Yu S, Yuan C, Huang M, et al.: Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA. Royal Society of Chemistry 2020,10 (57):34517–26 |.
• [51] Jeon M, Lin G, Stephen ZR, Kato FL, Zhang M: Paclitaxel‐loaded iron oxide nanoparticles for targeted breast cancer therapy. Advanced Therapeutics 2019,2 (12):1900081.
• [52] Zhong Y, Zhang J, Cheng R, Denga C, Meng F, Xie F, et al.: Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+human breast tumor xenografts. ournal of Controlled Release 2015,205:144–54.
• [53] Li M, Tang Z, Zhang Y, Lv S, Li Q, Chen X: Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis. Acta Biomaterialia 2015,18:132-43.
• [54] Maji R, Dey NS, Satapathy BS, Mukherjee B, Mondal S: Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy. International Journal of Nanomedicine 2014,9:3107.
• [55] Manaspon C, Viravaidya-Pasuwat K, Pimpha N: Preparation of folate-conjugated pluronic f127/chitosan core-shellnanoparticles encapsulating doxorubicin for breast cancer treatment. Journal of Nanomaterials 2012:1-12.
• [56] Abbasi S, Paul A, Shao W, Prakash S: Nanoparticles for targeted delivery of active agents against tumor cells. Journal of Drug Delivery 2012:1-8.
• [57] Suna B, Ranganathana B, Fenga S-S: Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 2008,29:475–86.
• [58] van Vlerken LE, Duan Z, Little SR, Seiden MV, Amiji MM: Biodistribution and pharmacokinetic analysis of paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model. Molecular Pharmaceutics 2006,5 (4):516–26.
• [59] Shubayev VI, Pisanic II TR, Jin S: Magnetic nanoparticles for theragnostics. Advanced Drug Delivery Reviews 2009,61 (6):467-77.
• [60] Wang Y, Liu H, Yao D, Li J, Yang S, Zhang C, et al.: 18F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts. Journal of Nanobiotechnology 2019,17 (1):105.
• [61] Nosrati H, Rashidi N, Danafar H, Manjili HK: Anticancer activity of tamoxifen loaded tyrosine decorated biocompatible Fe3O4 magnetic nanoparticles against breast cancer cell lines. Journal of Inorganic and Organometallic Polymers and Materials 2018,28 (3):1178-86.
• [62] Natesan S, Ponnusamy C, Sugumaran A, Chelladurai S, Shanmugam Palaniappan S, Palanichamy R: Artemisinin loaded chitosan magnetic nanoparticles for the efficient targeting to the breast cancer. International journal of biological macromolecules 2017,104:1853-9.
• [63] Yallapu MM, Othman SF, Curtis ET, Bauer NA, Chauhan N, Kumar D, et al.: Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. International Journal of Nanomedicine 2012,2 (7):1761-79.
• [64] Poonia N, Lather V, Pandita D: Mesoporous silica nanoparticles: a smart nanosystem for management of breast cancer. Drug Discovery Today 2018,23 (2):315-32.
• [65] Ali OM, Bekhit AA, Khattab SN, Helmy MW, Abdel-Ghany YS, Telebab M, et al.: Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy. Colloids and Surfaces B: Biointerfaces 2020,188:110824.
• [66] Bhavsar D, Gajjar J, Sawant K: Formulation and development of smart pH responsive mesoporous silica nanoparticles for breast cancer targeted delivery of anastrozole: In vitro and in vivo characterizations. Microporous and Mesoporous Materials 2019,279:107-16.
• [67] Mukherjee B, Chakraborty S, Mondal L, Satapathy BS, Sengupta S, Dutta L, et al.: Multifunctional drug nanocarriers facilitate more specific entry of therapeutic payload into tumors and control multiple drug resistance in cancer. In: Grumezescu AM, editor. Nanobiomaterials in Cancer Therapy, William Andrew Publishing: 2016. pp. 203-51. [68] Cho H, Lai TC, Tomoda K, Kwon GS: Polymeric micelles for multi-drug delivery in cancer. AAPS PharmSciTech, 2015,16 (1):10-20.
• [69] Gener Paea: Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells. Nanimedicine: Nanotexhnology Biology and Medicine 2020,24:102106
• [70] Xiang J, Wu B, Zhou Z, Hu S, Piao Y, Zhou Q, et al.: Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy. Science China Life Sciences 2018,61 (4):436-47.
• [71] Tan L, Ma B, Chen L, Peng J, Qian Z: Toxicity evaluation and anti-tumor study of docetaxel loaded mPEG-polyester micelles for breast cancer therapy. Journal of Biomedical Nanotechnology 2017,13 (4):393-408.
• [72] Bothiraja C, Kapare HS, Pawar AP, Shaikh KS: Development of plumbagin-loaded phospholipid–Tween®80 mixed micelles: formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing. Therapeutic Delivery 2013,4 (10):1247–59.
• [73] Lecot N, Glisoni R, Oddone N, Benech J, Fernández M, Gambini JP, et al.: Glucosylated polymeric micelles actively target a breast cancer model. Advanced Therapeutics 2021,4 (1):2000010.
• [74] Cui Y, Yang Y, Ma M, Xu Y, Sui J, Li H, et al.: Reductive responsive micelle overcoming multidrug resistance of breast cancer by co-delivery of DOX and specific antibiotic. Journal of Material Chemisry B 2019,7 (40):6075-86.
• [75] Zhang Y, Zhu X, Chen X, Chen Q, Zhou W, Guo Q, et al.: Activated platelets‐targeting micelles with controlled drug release for effective treatment of primary and metastatic triple negative breast cancer. Advaced Functional Materials 2019,29 (13):1806620.
• [76] Kesharwani SS, Dachineni R, Bhat GJ, Tummala H: Hydrophobically modified inulin-based micelles: Transport mechanisms and drug delivery applications for breast cancer. Journal of Drug Delivery Science and Technology 2019,54:101254.
• [77] Wang J, De G, Yue Q, Ma H, Cheng J, Zhu G, et al.: pH Responsive Polymer Micelles Enhances Inhibitory Efficacy on Metastasis of Murine Breast Cancer Cells. Frontiers in Pharmacology 2018,9 (543).
• [78] Pawar A, Singh S, Rajalakshmi S, Shaikh K, Bothiraja C: Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting. Artif Cells Nanomed Biotechnol 2018,46 (sup1):347-61.
• [79] Ji W, Wang B, Fan Q, Xu C, He Y, Chen Y: Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy. PLoS ONE 2017,12 (7):0180037.
• [80] Wang Y, Wang Y, Chen G, Li Y, Xu W, Gong S: Quantum-dot-based theranostic micelles conjugated with an anti-EGFR nanobody for triple-negative breast cancer therapy. ACS Applied Materials & Interfaces 2017,9 (36):30297-305.
• [81] Tang S, Meng Q, Sun H, Su J, Yin Q, Zhang Z, et al.: Dual pH-sensitive micelles with charge-switch for controlling cellular uptake and drug release to treat metastatic breast cancer. Biomaterials 2017,114:44-53.
• [82] Hassanzadeh F, Varshosaz J, Khodarahmi GA, Rostami M, Hassanzadeh F: Biotin-encoded pullulan-retinoic acid engineered nanomicelles: Preparation, optimization and in vitro cytotoxicity assessment in MCF-7 cells. Indian Journal of Pharmaceutical Sciences 2016,78 (5):557-65.
• [83] Brinkman AM, Chen G, Wang Y, Hedman CJ, Sherer NM, Havighurst TC, et al.: Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer. Biomaterials 2016,101:20-31.
• [84] Yu H, Cui Z, Yu P, Guo C, Feng B, Jiang T, et al.: pH‐and NIR light‐responsive micelles with hyperthermia‐triggered tumor penetration and cytoplasm drug release to reverse doxorubicin resistance in breast cancer. Advanced Functional Materials 2015,25 (17):2489-500.
• [85] Wang T, Yang S, A. ML, Parmar CK, Gillespie JW, Praveen KP, et al.: Paclitaxel-loaded peg-pe–based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumors. Molecular Cancer Therapeutics 2014,13 (12):2864-75.
• [86] Zhang X-y, Zhang P-y: Polymersomes in Nanomedicine - A Review Current Nanoscience 2017,13:124-9.
• [87] Zavvar T, Babaei M, Abnous K, Taghdisi SM, Nekooei S, Ramezani M, et al.: Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model. International Journal of Pharmaceutics 2020,578:119091.
• [88] Shahriari M, Taghdisi SM, Abnous K, Ramezani M, Alibolandi M: Synthesis of hyaluronic acid-based polymersomes for doxorubicin delivery to metastatic breast cancer. International Journal of Pharmaceutics 2019,572:118835.
• [89] Abolfazl Akbarzadeh, Rogaie Rezaei-Sadabady, Soodabeh Davaran, Sang Woo Joo, Nosratollah Zarghami, Younes Hanifehpour, et al.: Liposome: classification, preparation, and applications. Nanoscale Research Letters 2013,8:102.
• [90] Lee J-Y, Shin DH, Kim J-S: Anticancer effect of metformin in herceptin-conjugated liposome for breast cancer. Pharmaceutics 2020,12 (1):11.
• [91] Shukla SK, Kulkarni NS, Chan A, Parvathaneni V, Farrales P, Muth A, et al.: Metformin-encapsulated liposome delivery system: an effective treatment approach against breast cancer. Pharmaceutics 2019,11 (11):559.
• [92] Shemesh CS, Moshkelani D, Zhang H: Thermosensitive liposome formulated indocyanine green for near-infrared triggered photodynamic therapy: In vivo evaluation for triple-negative breast cancer. Pharmaceutical Research 2015,32:1604–14.
• [93] Coscoa D, Paolinoa D, Cilurzoa F, Casalea F, Frestaa M: Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases. International Journal of Pharmaceutics 2012,422:229– 37.
• [94] Chowdhury N, Chaudhry S, Hall Nea: Targeted delivery of doxorubicin liposomes for HER-2+ breast cancer treatment. AAPS PharmSciTech 2020,21 (202).
• [95] Fu M, Tang W, Liu J-J, Gong X-Q, Kong L, Yao X-M, et al.: Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer. Journal of Drug Targeting 2020,28 (3):245-58.
• [96] Zhao YN, Cao YN, Sun J, Liang Z, Wu Q, Cui SH, et al.: Anti-breast cancer activity of resveratrol encapsulated in liposomes. Journal of Material Chemisry B 2020,8 (1):27-37.
• [97] Ghafari M, Haghiralsadat F, Khanamani S, pour F, Reza JZ: Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy. Journal of Cellular Biochemistry 2020,121 (7):3584-92.
• [98] Okamoto Y, Taguchi K, Imoto S, Chuang VTG, Yamasaki K, Otagiri M: Cell uptake and anti-tumor effect of liposomes containing encapsulated paclitaxel-bound albumin against breast cancer cells in 2D and 3D cultured models. Journal of Drug Delivery Science and Technology 2020,55:101381.
• [99] Gheybi F, Alavizadeh SH, Rezayat SM, Zendedel E, Jaafari M: Chemotherapeutic activity of Silymarin combined with doxorubicin liposomes in 4T1 breast cancer cells. Nanomedicine Research Journal 2019,4 (1):29-34.
• [100] Alexander P, Jainamboo M, Praseetha PK, Gopukumar ST: Silica coated liposomes for drug delivery towards breast cancer cells. Rasayan Journal of Chemistry 2016,9 (3):300 - 8.
• [101] Jadia R, Kydd J, Piel B, Rai P: Liposomes aid curcumin's combat with cancer in a breast tumor model. Oncomedicine 2018,3:94-109.
• [102] Cao J, Wang R, Gao N, Li M, Tian X, Yang W, et al.: A7RC peptide modified paclitaxel liposomes dually target breast cancer. Biomaterials Science 2015,3 (12):1545-54.
• [103] Ağardan NBM, Değim Z, Yılmaz Ş, Altıntaş L, Topal T: The effectiveness of raloxifene-loaded liposomes and cochleates in breast cancer therapy. AAPS PharmSciTech 2016,17 (4):968-77.
• [104] Dadgar N, Esfahani MKM, Torabi S, Alavi SE, Akbarzadeh A: Effects of nanoliposomal and pegylated nanoliposomal artemisinin in treatment of breast cancer. Indian Journal of Clinical Biochemistry 2014,29 (4):501-4.
• [105] Odeh F, Ismail SI, Abu-Dahab R, Mahmoud IS, Bawab AAl: Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer. Drug Delivery 2012,19 (8):371-7.
• [106] Pindiprolu SKSS, Chintamaneni PK, Krishnamurthy PT, Ganapathineedi KRS: Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells. Drug Development and Industrial Pharmacy 2019,45 (2):304-13.
• [107] Guney EG, Cecener G, Dikmen G: Solid lipid nanoparticles: reversal of tamoxifen resistance in breast cancer. European Journal of Pharmaceutical Sciences 2018,120:73-88.
• [108] Mehnert W, Mader K: Solid lipid nanoparticles: production, characterization and applications. Advance Drug Delivery Review 2001,47:165-96.
• [109] Soni NK, Sonali LJ, Singh A, Mangla B, Neupane YR, Kohli K: Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment. Nanotechnology 2020,31 (47):475101.
• [110] Zafar S, Akhter S, Ahmad I, Hafeeze Z, Rizvi MAM, Jain GK, et al.: Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan Grafted Lipid Nanocapsules: Formulation optimization, in vitro and in vivo studies. Colloids and Surfaces B: Biointerfaces 2020,186:110603.
• [111] Miller WHJ, Schipper HM, Lee JS, Singer J, Waxman S: Mechanisms of action of arsenic trioxide. Cancer Research 2002,62:3893–903.
• [112] Ahn RW, Chen F, Chen H, Stern ST, Clogston JD, Patri AK, et al.: A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer. Clinical Cancer Research 2010,16 (14):3607-17.
• [113] Chen H, MacDonald RC, Li S, Krett NL, Rosen ST, O’Halloran TV: Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release. Journal of american Chemical Society 2006,128:13348-9.
• [114] Agarwal A, Ng WJ, Liu Y: Principle and applications of microbubble and nanobubble technology for water treatment. Chemosphere 2011,84 (9):1175-80.
• [115] Hui J, Wen C, Shouqiang L, Bolin W, Xiaoping L, Shouping X, et al.: Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy. Colloids and Surfaces B: Biointerfaces 2016,146:387–95.
• [116] Mahjour A, Khazaei M, Nourmohamadi E, Sarkarizi HK: Evaluation of antitumor effect of oxygen nanobubble water on breast cancer‐bearing BALB/c mice. Journal of Cellular Biochemistry 2019,120 (9):15546-52.